This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human VEGFR1/Flt-1 DuoSet ELISA
catalog :
DY321B
quantity :
1 Kit (for 15 Plates)
price :
850 USD
citations: 28
Reference
L xf3 pez Guzm xe1 n C, Garc xed a A, Mar xed n P, V xe1 squez A. Assessment of the Integrity and Function of Human Term Placental Explants in Short-Term Culture. Methods Protoc. 2024;7: pubmed publisher
Lekva T, Sundaram A, Roland M, xc5 sheim J, Michelsen A, Norwitz E, et al. Platelet and mitochondrial RNA is decreased in plasma-derived extracellular vesicles in women with preeclampsia-an exploratory study. BMC Med. 2023;21:458 pubmed publisher
Kadife E, Hannan N, Harper A, Binder N, Beard S, Brownfoot F. Hydroxychloroquine reduces soluble Flt-1 secretion from human cytotrophoblast, but does not mitigate markers of endothelial dysfunction in vitro. PLoS ONE. 2022;17:e0271560 pubmed publisher
Fato B, De Alwis N, Beard S, Binder N, Pritchard N, Tong S, et al. Serum Collected from Preeclamptic Pregnancies Drives Vasoconstriction of Human Omental Arteries-A Novel Ex Vivo Model of Preeclampsia for Therapeutic Development. Int J Mol Sci. 2022;23: pubmed publisher
MacDonald S, Bosio E, Shapiro N, Balmer L, Burrows S, Hibbs M, et al. No association between intravenous fluid volume and endothelial glycocalyx shedding in patients undergoing resuscitation for sepsis in the emergency department. Sci Rep. 2022;12:8733 pubmed publisher
Lean S, Jones R, Roberts S, Heazell A. A prospective cohort study providing insights for markers of adverse pregnancy outcome in older mothers. BMC Pregnancy Childbirth. 2021;21:706 pubmed publisher
De Alwis N, Beard S, Binder N, Pritchard N, Kaitu u Lino T, Walker S, et al. NR4A2 expression is not altered in placentas from cases of growth restriction or preeclampsia, but is reduced in hypoxic cytotrophoblast. Sci Rep. 2021;11:20670 pubmed publisher
Sun Y, Tan L, Neuman R, Broekhuizen M, Schoenmakers S, Lu X, et al. Megalin, Proton Pump Inhibitors and the Renin-Angiotensin System in Healthy and Pre-Eclamptic Placentas. Int J Mol Sci. 2021;22: pubmed publisher
Hong S, Lee J, Kim Y, Park Y, Choi J, Park K. Identifying potential biomarkers related to pre-term delivery by proteomic analysis of amniotic fluid. Sci Rep. 2020;10:19648 pubmed publisher
Gierman L, Silva G, Pervaiz Z, Rakner J, Mundal S, Thaning A, et al. TLR3 expression by maternal and fetal cells at the maternal-fetal interface in normal and preeclamptic pregnancies. J Leukoc Biol. 2021;109:173-183 pubmed publisher
Eddy A, Chapman H, Brown D, George E. Differential regulation of sFlt-1 splicing by U2AF65 and JMJD6 in placental-derived and endothelial cells. Biosci Rep. 2020;40: pubmed publisher
Djeha A, Girard S, Trottier H, Kakkar F, Soudeyns H, Boucher M, et al. No association between early antiretroviral therapy during pregnancy and plasma levels of angiogenic factors: a cohort study. BMC Pregnancy Childbirth. 2019;19:482 pubmed publisher
Brownfoot F, Hannan N, Cannon P, Nguyen V, Hastie R, Parry L, et al. Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction. EBioMedicine. 2019;41:636-648 pubmed publisher
Hannan N, Binder N, Beard S, Nguyen T, Kaitu u Lino T, Tong S. Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia. PLoS ONE. 2018;13:e0187082 pubmed publisher
Mésange P, Bouygues A, Ferrand N, Sabbah M, Escargueil A, Savina A, et al. Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of RAS Status. Clin Cancer Res. 2018;24:2548-2558 pubmed publisher
Lean S, Heazell A, Dilworth M, Mills T, Jones R. Placental Dysfunction Underlies Increased Risk of Fetal Growth Restriction and Stillbirth in Advanced Maternal Age Women. Sci Rep. 2017;7:9677 pubmed publisher
Krämer B, Schultz J, Hock C, Sauter A, Stuck B, Hormann K, et al. Effect of selective small molecule inhibitors on MMP-9 and VEGFR-1 expression in p16-positive and -negative squamous cell carcinoma. Oncol Lett. 2017;13:3269-3276 pubmed publisher
McDonald C, Darling A, Liu E, Tran V, Cabrera A, Aboud S, et al. Angiogenic proteins, placental weight and perinatal outcomes among pregnant women in Tanzania. PLoS ONE. 2016;11:e0167716 pubmed publisher
Kumar N, Moideen K, Sivakumar S, Menon P, Viswanathan V, Kornfeld H, et al. Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors. J Infect. 2017;74:10-21 pubmed publisher
Kumar N, Banurekha V, Nair D, Babu S. Circulating Angiogenic Factors as Biomarkers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis. PLoS ONE. 2016;11:e0146318 pubmed publisher
McDonald C, Darling A, Conroy A, Tran V, Cabrera A, Liles W, et al. Inflammatory and Angiogenic Factors at Mid-Pregnancy Are Associated with Spontaneous Preterm Birth in a Cohort of Tanzanian Women. PLoS ONE. 2015;10:e0134619 pubmed publisher
Conroy A, Gélvez M, Hawkes M, Rajwans N, Liles W, Villar Centeno L, et al. Host biomarkers distinguish dengue from leptospirosis in Colombia: a case-control study. BMC Infect Dis. 2014;14:35 pubmed publisher
Munaut C, Lorquet S, Pequeux C, Coulon C, Le Goarant J, Chantraine F, et al. Differential expression of Vegfr-2 and its soluble form in preeclampsia. PLoS ONE. 2012;7:e33475 pubmed publisher
Kaitu u Lino T, Whitehead C, Ngian G, Permezel M, Tong S. Serum concentrations of soluble Flt-1 are decreased among women with a viable fetus and no symptoms of miscarriage destined for pregnancy loss. PLoS ONE. 2012;7:e32509 pubmed publisher
Conroy A, Liles W, Molyneux M, Rogerson S, Kain K. Performance characteristics of combinations of host biomarkers to identify women with occult placental malaria: a case-control study from Malawi. PLoS ONE. 2011;6:e28540 pubmed publisher
Erdman L, Dhabangi A, Musoke C, Conroy A, Hawkes M, Higgins S, et al. Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study. PLoS ONE. 2011;6:e17440 pubmed publisher
Lash G, Naruse K, Innes B, Robson S, Searle R, Bulmer J. Secretion of angiogenic growth factors by villous cytotrophoblast and extravillous trophoblast in early human pregnancy. Placenta. 2010;31:545-8 pubmed publisher
Kishuku M, Nishioka Y, Abe S, Kishi J, Ogino H, Aono Y, et al. Expression of soluble vascular endothelial growth factor receptor-1 in human monocyte-derived mature dendritic cells contributes to their antiangiogenic property. J Immunol. 2009;183:8176-85 pubmed publisher
product information
master code :
DY321B
SKU :
DY321B
product name :
Human VEGFR1/Flt-1 DuoSet ELISA
unit size :
1 Kit (for 15 Plates)
description :
The Human VEGFR1/Flt-1 DuoSet ELISA from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human VEGFR1/Flt-1.
target :
VEGFR1/Flt-1
category :
ELISAs
species :
Human
gene symbol :
FLT1
kit type :
Solid Phase Sandwich ELISA
elisaRange :
125.00 - 8000 pg/mL
top caption :
Human VEGF R1/ Flt-1 ELISA Standard Curve
applications :
ELISA
USD :
850 USD
alt names :
EC 2.7.10, EC 2.7.10.1, FLT, FLT1, FLT-1, Fms-like tyrosine kinase 1, fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascularpermeability factor receptor), FRT, Tyrosine-protein kinase FRT, Tyrosine-protein kinase receptor FLT, vascular endothelial growth factor receptor 1, Vascular permeability factor receptor, VEGF R1, VEGFR1, VEGFR-1
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.